Biomarkers in Cardiorenal Syndromes
Related Experiment Video
Updated: Feb 11, 2026

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
Published on: October 10, 2012
Shihui Fu1,2, Shaopan Zhao1, Ping Ye1
1Department of Geriatric Cardiology, Chinese People's Liberation Army General Hospital, Beijing 100853, China.
Insights
Cardiorenal syndromes (CRS) involve heart and kidney dysfunction. Biomarkers show promise for identifying CRS patients and guiding treatment, but more research is needed.
Area of Science:
- Cardiology
- Nephrology
- Biomarker Research
Background:
- Cardiorenal syndromes (CRS) involve interconnected heart and kidney dysfunction.
- Patients with CRS face higher hospitalization and mortality risks.
- Accurate identification of CRS is crucial for patient outcomes.
Purpose of the Study:
- To explore the role of biomarkers in identifying cardiorenal syndromes.
- To assess the potential of biomarkers in prognosis and therapy guidance for CRS.
- To highlight the need for further biomarker research in CRS.
Main Methods:
- Review of current understanding of cardiorenal syndromes.
- Analysis of the utility of existing biomarkers in heart and kidney disease.
- Discussion of the emerging role of biomarkers in CRS.
Main Results:
- Biomarkers can predict outcomes in heart failure and renal disease.
- Biomarkers are valuable for detecting cardiac issues in kidney disease and vice versa.
- Current research on biomarkers specifically for CRS is in its early stages.
Conclusions:
- Biomarkers hold significant potential for diagnosing CRS and informing treatment strategies.
- Further investigation into current and novel biomarkers is essential for improving CRS management.
- Enhanced biomarker research is key to advancing the diagnosis, therapy, and prognosis of cardiorenal syndromes.
Abstract:
There is a consensus that cardiorenal syndromes (CRS) are defined as the disorders of heart and kidney where acute or chronic dysfunction in one organ may induce acute or chronic dysfunction in another. Patients with CRS have increased hospitalization and mortality rates, and thus their identification is of great implication. Biomarkers are not only predictive in heart failure or renal diseases, but also useful in identifying cardiac dysfunction in renal diseases and renal injury in heart failure. Thus, they may be applied in order to identify patients with CRS and even assess prognosis and guide therapy in these patients. However, studies on biomarkers have just begun in CRS. Future studies are essential to observe current biomarkers and find novel biomarkers in CRS so as to improve diagnosis, therapy, and prognosis of CRS.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Acute Coronary Syndrome I: Introduction
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Restless Leg Syndrome and Night Terrors
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
Acute Coronary Syndrome V: Nursing Management

